359 related articles for article (PubMed ID: 31489621)
1. The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women.
Alves RDMS; Rabelo MM; Andrade VR; Cabral RCS; Merriman JW; Brito MB
Int J Gynaecol Obstet; 2019 Dec; 147(3):326-331. PubMed ID: 31489621
[TBL] [Abstract][Full Text] [Related]
2. Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems.
Frenz AK; Ahlers C; Beckert V; Gerlinger C; Friede T
Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):48-57. PubMed ID: 33269954
[TBL] [Abstract][Full Text] [Related]
3. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
5. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
[TBL] [Abstract][Full Text] [Related]
6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
7. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.
Backman T
Drug Saf; 2004; 27(15):1185-204. PubMed ID: 15588115
[TBL] [Abstract][Full Text] [Related]
8. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
[TBL] [Abstract][Full Text] [Related]
10. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
12. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
[TBL] [Abstract][Full Text] [Related]
13. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
14. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of a 52-mg levonorgestrel-releasing intrauterine system in women with cardiovascular disease.
Ueda Y; Kamiya CA; Horiuchi C; Miyoshi T; Hazama R; Tsuritani M; Iwanaga N; Neki R; Ikeda T; Yoshimatsu J
J Obstet Gynaecol Res; 2019 Feb; 45(2):382-388. PubMed ID: 30259601
[TBL] [Abstract][Full Text] [Related]
16. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects.
da Silva AV; de Melo AS; Barboza RP; de Paula Martins W; Ferriani RA; Vieira CS
Reprod Sci; 2016 Jul; 23(7):877-84. PubMed ID: 26733500
[TBL] [Abstract][Full Text] [Related]
18. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
Selim MF; Hussein AF
Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
[TBL] [Abstract][Full Text] [Related]
19. Effect of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers among women with thrombophilia or previous venous thromboembolism.
Braga GC; Brito MB; Ferriani RA; Oliveira LC; Garcia AA; Pintão MC; Vieira CS
Int J Gynaecol Obstet; 2020 Mar; 148(3):381-385. PubMed ID: 31778208
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial.
Gemzell-Danielsson K; Apter D; Hauck B; Schmelter T; Rybowski S; Rosen K; Nelson A
PLoS One; 2015; 10(9):e0135309. PubMed ID: 26378938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
